Literature DB >> 15911745

cMet and Fas receptor interaction inhibits death-inducing signaling complex formation in endothelial cells.

Lesley Ann Smyth1, Hugh J M Brady.   

Abstract

Fas receptor is constitutively expressed on endothelial cells; however, these cells are highly resistant to Fas-mediated apoptosis. In this study, we examined death-inducing signaling complex (DISC) formation in endothelial cells after Fas receptor stimulation. Nonfunctional DISC formation was observed in human umbilical vein endothelial cells (HUVECs). Fas-associated death domain (FADD) and large amounts of FADD-like interleukin-1--converting enzyme--inhibitory protein-L were recruited to the receptor; however, no caspase 8 recruitment was observed. A role for the cell surface molecule cMet in controlling Fas sensitivity in endothelial cells was observed. Here, we report that Fas is associated with cMet in HUVECs. Such an interaction may inhibit self-association of Fas in these cells, as suggested by the fact that monomeric Fas is expressed in these cells. Endothelial cells undergoing cell matrix detachment, anoikis, are sensitive to Fas-mediated apoptosis. Despite upregulating the level of Fas receptor, endothelial cells undergoing anoikis have reduced cMet/Fas interaction, in part because of cMet being cleaved in these cells. Dimeric Fas was observed on anoikis cells. These data suggest that cMet/Fas interaction may inhibit self-association of Fas receptor such that reduced DISC formation occurs in these cells after Fas receptor ligation. cMet/Fas interaction may help explain why endothelial cells are resistant to Fas-mediated apoptosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15911745     DOI: 10.1161/01.HYP.0000167991.82153.16

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  11 in total

1.  Novel proapoptotic effect of hepatocyte growth factor: synergy with palmitate to cause pancreatic {beta}-cell apoptosis.

Authors:  José A González-Pertusa; John Dubé; Shelley R Valle; Taylor C Rosa; Karen K Takane; José M Mellado-Gil; Germán Perdomo; Rupangi C Vasavada; Adolfo García-Ocaña
Journal:  Endocrinology       Date:  2010-02-22       Impact factor: 4.736

2.  Inhibition of Fas-Fas ligand interaction attenuates microvascular hyperpermeability following hemorrhagic shock.

Authors:  Devendra A Sawant; Binu Tharakan; Richard P Tobin; Hayden W Stagg; Felicia A Hunter; M Karen Newell; W Roy Smythe; Ed W Childs
Journal:  Shock       Date:  2013-02       Impact factor: 3.454

3.  Mechanism of Fas signaling regulation by human herpesvirus 8 K1 oncoprotein.

Authors:  Zuzana Berkova; Shu Wang; Jillian F Wise; Hoyoung Maeng; Yuan Ji; Felipe Samaniego
Journal:  J Natl Cancer Inst       Date:  2009-03-10       Impact factor: 13.506

4.  AXL mediates TRAIL resistance in esophageal adenocarcinoma.

Authors:  Jun Hong; Abbes Belkhiri
Journal:  Neoplasia       Date:  2013-03       Impact factor: 5.715

5.  Promotion of Fas-mediated apoptosis in Type II cells by high doses of hepatocyte growth factor bypasses the mitochondrial requirement.

Authors:  Yongge Zhao; Daniell Difrancesca; Xue Wang; Reza Zarnegar; George K Michalopoulos; Xiao-Ming Yin
Journal:  J Cell Physiol       Date:  2007-11       Impact factor: 6.384

6.  Switch from type II to I Fas/CD95 death signaling on in vitro culturing of primary hepatocytes.

Authors:  Dorothée Walter; Kathrin Schmich; Sandra Vogel; Robert Pick; Thomas Kaufmann; Florian Christoph Hochmuth; Angelika Haber; Karin Neubert; Sabine McNelly; Fritz von Weizsäcker; Irmgard Merfort; Ulrich Maurer; Andreas Strasser; Christoph Borner
Journal:  Hepatology       Date:  2008-12       Impact factor: 17.425

7.  Hepatocyte Growth Factor Modulates MET Receptor Tyrosine Kinase and β-Catenin Functional Interactions to Enhance Synapse Formation.

Authors:  Zhihui Xie; Kathie L Eagleson; Hsiao-Huei Wu; Pat Levitt
Journal:  eNeuro       Date:  2016-08-29

8.  Novel Combination BMP7 and HGF Gene Therapy Instigates Selective Myofibroblast Apoptosis and Reduces Corneal Haze In Vivo.

Authors:  Suneel Gupta; Michael K Fink; Arkasubhra Ghosh; Ratnakar Tripathi; Prashant R Sinha; Ajay Sharma; Nathan P Hesemann; Shyam S Chaurasia; Elizabeth A Giuliano; Rajiv R Mohan
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-02-01       Impact factor: 4.799

Review 9.  c-Met and Other Cell Surface Molecules: Interaction, Activation and Functional Consequences.

Authors:  Giuditta Viticchiè; Patricia A J Muller
Journal:  Biomedicines       Date:  2015-01-15

10.  Targeting c-Met receptor overcomes TRAIL-resistance in brain tumors.

Authors:  Wanlu Du; Liubov Uslar; Sindhura Sevala; Khalid Shah
Journal:  PLoS One       Date:  2014-04-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.